The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.407%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of Share Options

11 Feb 2021 16:30

RNS Number : 8596O
Ilika plc
11 February 2021
 

 

 

Ilika plc

("Ilika" or the "Company")

 

Award of Share Options, Director/ PDMR shareholding, Exercise of Options and Total Voting Rights 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that on 10 February 2021 in aggregate nominal value options over 179,903 ordinary shares of 1p each in the Company ("Ordinary Shares") were granted to the Executive Directors under the Company's Long Term Incentive Plan 2018. Each award vests on the achievement of certain performance targets over a three-year period. In addition, on 10 February 2021, the Executive Directors sold 6,500 shares each, in aggregate 19,500 shares, primarily to cover tax liabilities arising from options exercised in 2020, previously awarded under the Company's bonus scheme.

 

Details of grants issued to the Executive Directors' under the Company's Long Term Incentive Plan 2018 and Ordinary Shares sold by each Executive Director are set out in the tables below, together with the total number of Ordinary Shares each Executive Director holds under option and is interested in.

 

Director

Number of options granted

Total number of options held post grant

Options held as per cent. of issued share capital

Graeme Purdy

92,536

2,205,178

1.59

Brian Hayden

44,494

1,232,565

0.89

Steve Boydell

42,873

698,316

0.50

 

Director

Ordinary Shares sold

Number of Ordinary Shares held post sale

Ordinary Shares held as per cent. of issued share capital

Graeme Purdy

6,500

767,927

0.55

Brian Hayden(1)

6,500

33,500

0.02

Steve Boydell

6,500

43,346

0.03

 

(1)Brian Hayden holds 426,300 preference shares in the Company.

 

Exercise of Options

 

Following the vesting of options under the Company's EMI share option schemes, 412,575 options with an exercise price of 21p, together with 28,285 options with an exercise price of 53p, have been converted into Ordinary Shares. Accordingly, the Company has applied to the London Stock Exchange for 440,860 Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00am on 16th February 2021.

 

The options represent in aggregate 0.32 per cent of the Company's issued share capital.

 

Total Voting Rights

 

Following Admission, the Company's issued share capital will comprise 139,038,172 Ordinary Shares, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury. 

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation.

For more information contact:

 

Ilika plc

 

 

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan, William Hall, Nikhil Varghese

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Tom Cooper

Mob: 0797 122 1972

Lianne Cawthorne

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Graeme Purdy

2

Reason for the notification

 

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Ilika plc

b)

LEI

213800TMDNIE3Z8XXD26

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

 

 

Identification code

GB00B608Z994

 

 

b)

Nature of the transaction

 

a) Grant of share options

b) Sale of shares

c)

 

Price(s) and volume(s)

 

 a)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

92,536

 

 

 

 

 

 

 

 

b)

 

 

 

 

Price(s)

Volume(s)

 

 

 

267.8p

6,500

 

 

 

 

 

 

d)

 

Aggregated information

a) Not Applicable - Single Transaction

b) Not Applicable - Single Transaction

 

 

- Aggregated volume

 

 

 

- Price

 

 

e)

Date of the transaction

a) 10 February 2021

b) 10 February 2021

f)

Place of the transaction

a) Off market

b) AIMX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Brian Hayden

2

Reason for the notification

 

a)

Position/status

Chief Scientific Officer

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Ilika plc

b)

LEI

213800TMDNIE3Z8XXD26

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

 

 

Identification code

GB00B608Z994

 

 

b)

Nature of the transaction 

a) Grant of share options

b) Sale of shares

c)

 

Price(s) and volume(s)

 

 a)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

44,494

 

 

 

 

 

 

 

 

b)

 

 

 

 

Price(s)

Volume(s)

 

 

 

265.25p

6,500

 

 

 

 

 

 

d)

 

Aggregated information

a) Not Applicable - Single Transaction

b) Not Applicable - Single Transaction

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

Date of the transaction

a) 10 February 2021

b) 10 February 2021

f)

Place of the transaction

a) Off market

b) AIMX

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Steve Boydell

2

Reason for the notification

 

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Ilika plc

b)

LEI

213800TMDNIE3Z8XXD26

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

 

 

Identification code

GB00B608Z994

 

 

b)

Nature of the transaction 

a) Grant of share options

b) Sale of shares

c)

 

Price(s) and volume(s)

 

 a)

 

 

 

 

Price(s)

Volume(s)

 

 

 

1p

42,873

 

 

 

 

 

 

 

 

b)

 

 

 

 

Price(s)

Volume(s)

 

 

 

268.0p

6,500

 

 

 

 

 

 

d)

 

Aggregated information

a) Not Applicable - Single Transaction

b) Not Applicable - Single Transaction

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

Date of the transaction

a) 10 February 2021

b) 10 February 2021

f)

Place of the transaction

a) Off market

b) AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUAUNRAVUUAAR
Date   Source Headline
12th Nov 20137:00 amRNSHalf Year Trading Update
28th Oct 20137:00 amRNSIlika expands into Aerospace Sector
21st Oct 20137:00 amRNSInvestor Teach-in
17th Sep 20134:09 pmRNSResult of AGM
17th Sep 20137:00 amRNSAGM Statement
16th Sep 20137:00 amRNSTwo New Customers in Europe
23rd Aug 20131:25 pmRNSPosting of Annual Report & Notice of AGM
2nd Aug 20135:02 pmRNSConversion of Securities
30th Jul 20137:00 amRNSContract Renewals and Grant Award
19th Jul 20132:50 pmRNSHolding(s) in Company
19th Jul 201311:17 amRNSHolding(s) in Company
18th Jul 20137:00 amRNS£3.3 million EPSRC Grant Award to Southampton Univ
15th Jul 20137:00 amRNSFinal Results
21st May 20131:09 pmRNSHolding(s) in Company
20th May 20137:00 amRNSDirectorate Change and Conversion of Securities
17th May 20133:57 pmRNSPlacing - Replacement
17th May 20137:00 amRNSPlacing
1st May 20137:00 amRNSFuel Cell Catalyst Patent Granted in Japan
22nd Apr 20137:00 amRNSContract with new European Customer
16th Apr 20137:00 amRNSTrading Update
21st Feb 20137:00 amRNSRenewal of Contract
29th Jan 20137:00 amRNSCompletion of Laboratory Facility Expansion
18th Jan 20133:28 pmRNSHolding(s) in Company
17th Jan 20135:46 pmRNSHolding(s) in Company
17th Jan 201311:16 amRNSHolding(s) in Company
15th Jan 20135:21 pmRNSHolding(s) in Company
10th Jan 20137:00 amRNSInterim Results
21st Dec 20127:00 amRNSGrant of Fuel Cell Catalyst Patent
18th Dec 20121:41 pmRNSCompletion of Disposal
17th Dec 20127:00 amRNSConversion of Securities
11th Dec 20127:00 amRNSRenewal of Contract
29th Nov 20124:44 pmRNSHolding(s) in Company
28th Nov 20125:00 pmRNSHolding(s) in Company
27th Nov 20122:18 pmRNSHolding(s) in Company
19th Nov 20127:00 amRNSEnergizer Relationship Update
22nd Oct 20127:00 amRNSTrading Update
5th Oct 20127:00 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSTotal Voting Rights
18th Sep 20127:00 amRNSDiscontinuing of wound care products and services
14th Sep 20127:00 amRNSCarbon Trust Investment
7th Sep 20121:27 pmRNSResult of AGM
7th Sep 20127:00 amRNSAGM Statement
9th Aug 20127:00 amRNSPosting of Annual Report & Notice of AGM
19th Jul 20127:00 amRNSFinal Results
14th Jun 20127:14 amRNSChange of Adviser
1st Jun 201210:01 amRNSTotal Voting Rights
18th May 20127:00 amRNSTrading Update
17th May 20127:00 amRNSConversion of Securities
2nd May 20127:00 amRNSVapour Deposition Method US Patent Grant
1st May 20123:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.